OK Biotech Co., Ltd.

TWSE:4155 Stock Report

Market Cap: NT$3.1b

OK Biotech Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chia-De Lai

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.2%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

Aug 20
OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Apr 26
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

Apr 04
Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Mar 01
Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

Feb 15
Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

A Look At OK Biotech's (TPE:4155) Share Price Returns

Jan 31
A Look At OK Biotech's (TPE:4155) Share Price Returns

We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Jan 17
We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Jan 03
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Dec 21
Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Nov 23
Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

CEO

Chia-De Lai

no data

Tenure

Mr. Chia-De Lai serves as the Chairman and Managing Director of OK Biotech Co., Ltd and serves as its General Manager.

Board Members

NamePositionTenureCompensationOwnership
Chia-De Lai
General Managerno datano data0.23%
NT$ 7.0m
Qi Zheng Hou
CFO, Financial Managerless than a yearno data0.021%
NT$ 636.8k
De Zhang
Chief Operating Officerno datano datano data
De Wang
Business Office Associateno datano datano data
Yuan Chen
Independent Directorno datano datano data
Yun Xie
Independent Directorno datano datano data
Chao Jiang
Independent Directorno datano datano data
Li He
Independent Directorno datano data0.042%
NT$ 1.3m
De Zhang
Directorno datano data2.03%
NT$ 62.2m
Ching Piao Chen
Directorless than a yearno data0.99%
NT$ 30.3m
Chen Kang Wang
Directorless than a yearno data0.099%
NT$ 3.0m
Chin Yuan Hsu
Directorless than a yearno datano data

0.4yrs

Average Tenure

Experienced Board: 4155's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 15:38
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OK Biotech Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.
Yijun ChenSinoPac Securities Investment Service